Patients with high CRG scores had substantially higher frequencies of TP53, KRAS, CDKN2, SMAD4, and TTN mutations than patients with low CRG scores, implying that these gene mutations were in charge of the poor prognosis of PC patients with high CRG scores. This evidence concerns the gene KRAS and pachyonychia congenita.